People

Patrick Markus Aisher

Patrick Markus Aisher, commonly published as Patrick Aisher, is chairman of Kinled Holding. His current Danube Labs biography describes life-sciences investing since1997, with biomedical device, biopharmaceutical and healthcare-service investments, and directorships at Aleva Neurotherapeutics and PreComb Therapeutics. It describes sourcing university spin-outs across Europe and the United States; its portfolio and exit counts are self-reported career figures. A primary 2012 SEC corporate biography gives his full legal name, British-Austrian background, university study in Canada and the United Kingdom, engineering investments since1992 and a directorship at Hong Kong Kinled Holding Ltd. Current manager sources identify chairman; an undated page title referring to CEO does not establish a second current role or an appointment date. Mountain Labs AG named Patrick Aisher as a principal/key person in its 2023 SECA yearbook entry. The 2024 entry names only Thomas de Camborne Lucy, so Aisher’s exact current Mountain Labs role and term are not assumed.